Redhill Biopharma
RDHL
#10476
Rank
NZ$6.84 M
Marketcap
NZ$2.06
Share price
-0.83%
Change (1 day)
-83.93%
Change (1 year)

Redhill Biopharma (RDHL) - Net assets

Net assets on the balance sheet as of June 2025 : -NZ$7.63 Million

According to Redhill Biopharma's latest financial reports the company has -NZ$7.63 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Redhill Biopharma - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-NZ$8.31 Million-353.8%
2023-12-31$NZ$3.27 M-104.29%
2022-12-31$-NZ$76.24 Million-686.7%
2021-12-31$NZ$12.99 M-32.38%
2020-12-31$NZ$19.21 M-78.43%
2019-12-31$NZ$89.09 M16.75%
2018-12-31$NZ$76.3 M20.26%
2017-12-31$NZ$63.45 M-29.9%
2016-12-31$NZ$90.51 M3.12%
2015-12-31$NZ$87.77 M174.98%
2014-12-31$NZ$31.92 M119.97%
2013-12-31$NZ$14.51 M-37.23%
2012-12-31$NZ$23.11 M-3.96%
2011-12-31$NZ$24.07 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sanofi
SNY
NZ$149.13 B-1,956,065.55%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$89.70 B-1,176,595.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$36.59 B-480,063.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Taro Pharmaceutical
TARO
NZ$3.07 B-40,423.89%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Teva Pharmaceutical Industries
TEVA
NZ$12.53 B-164,515.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel